IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-58678-6.html
   My bibliography  Save this article

Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

Author

Listed:
  • Alex Soupir

    (Moffitt Cancer Center)

  • Oscar E. Ospina

    (Moffitt Cancer Center)

  • Oliver Hampton

    (Aster Insights)

  • Michelle Churchman

    (Aster Insights)

  • Michael Radmacher

    (Aster Insights)

  • Dale Hedges

    (Aster Insights)

  • David McKean

    (Aster Insights)

  • Phaedra Agius

    (Aster Insights)

  • Saman Zeeshan

    (University of Missouri)

  • Nathan D. Seligson

    (University of Florida)

  • Raphael Pollock

    (The Ohio State University Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center)

  • David Liebner

    (The Ohio State University Wexner Medical Center)

  • James L. Chen

    (The Ohio State University Wexner Medical Center)

  • Gabriel Tinoco

    (The Ohio State University Wexner Medical Center)

  • Bodour Salhia

    (Los Angeles)

  • Martin McCarter

    (University of Colorado School of Medicine)

  • Breelyn A. Wilky

    (University of Colorado School of Medicine)

  • Benjamin J. Miller

    (University of Iowa)

  • Michael J. Cavnar

    (University of Kentucky)

  • John S. Groundland

    (Huntsman Cancer Institute)

  • Bryan P. Schneider

    (Indiana University Simon Comprehensive Cancer Center)

  • Gregory Riedlinger

    (Rutgers Cancer Institute of New Jersey)

  • Stephen B. Edge

    (Roswell Park Comprehensive Cancer Center)

  • Christopher A. Moskaluk

    (University of Virginia)

  • Kenneth Cardona

    (Emory University)

  • Abdul Rafeh Naqash

    (University of Oklahoma Health Sciences)

  • Ricardo J. Gonzalez

    (Moffitt Cancer Center)

  • John E. Mullinax

    (Moffitt Cancer Center)

  • David M. Joyce

    (Moffitt Cancer Center)

  • Odion Binitie

    (Moffitt Cancer Center)

  • G. Douglas Letson

    (Moffitt Cancer Center)

  • Arash O. Naghavi

    (Moffitt Cancer Center)

  • Mihaela Druta

    (Moffitt Cancer Center)

  • Damon R. Reed

    (Moffitt Cancer Center)

  • Erin M. Siegel

    (Moffitt Cancer Center)

  • Jamie K. Teer

    (Moffitt Cancer Center)

  • Brooke L. Fridley

    (Moffitt Cancer Center
    Children’s Mercy)

  • Andrew S. Brohl

    (Moffitt Cancer Center)

Abstract

Given their rarity and diversity, a fundamental understanding of the genomic underpinnings for many sarcoma subtypes is still lacking. To better define the molecular landscape of this group of diseases, we perform matched whole exome sequencing and RNA sequencing on a cohort of 1340 sarcoma tumor specimens. We identify recurrent somatic mutations and observe an increased mutational burden in metastatic vs. primary samples (p

Suggested Citation

  • Alex Soupir & Oscar E. Ospina & Oliver Hampton & Michelle Churchman & Michael Radmacher & Dale Hedges & David McKean & Phaedra Agius & Saman Zeeshan & Nathan D. Seligson & Raphael Pollock & David Lieb, 2025. "Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes," Nature Communications, Nature, vol. 16(1), pages 1-11, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58678-6
    DOI: 10.1038/s41467-025-58678-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-58678-6
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-58678-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Florent Petitprez & Aurélien Reyniès & Emily Z. Keung & Tom Wei-Wu Chen & Cheng-Ming Sun & Julien Calderaro & Yung-Ming Jeng & Li-Ping Hsiao & Laetitia Lacroix & Antoine Bougoüin & Marco Moreira & Gui, 2020. "B cells are associated with survival and immunotherapy response in sarcoma," Nature, Nature, vol. 577(7791), pages 556-560, January.
    2. Mrinal M. Gounder & Narasimhan P. Agaram & Sally E. Trabucco & Victoria Robinson & Richard A. Ferraro & Sherri Z. Millis & Anita Krishnan & Jessica Lee & Steven Attia & Wassim Abida & Alexander Drilon, 2022. "Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    3. Benjamin A. Nacev & Francisco Sanchez-Vega & Shaleigh A. Smith & Cristina R. Antonescu & Evan Rosenbaum & Hongyu Shi & Cerise Tang & Nicholas D. Socci & Satshil Rana & Rodrigo Gularte-Mérida & Ahmet Z, 2022. "Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Shaoshuai Tang & Yunzhi Wang & Rongkui Luo & Rundong Fang & Yufeng Liu & Hang Xiang & Peng Ran & Yexin Tong & Mingjun Sun & Subei Tan & Wen Huang & Jie Huang & Jiacheng Lv & Ning Xu & Zhenmei Yao & Qi, 2024. "Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    2. Miles C. Andrews & Junna Oba & Chang-Jiun Wu & Haifeng Zhu & Tatiana Karpinets & Caitlin A. Creasy & Marie-Andrée Forget & Xiaoxing Yu & Xingzhi Song & Xizeng Mao & A. Gordon Robertson & Gabriele Roma, 2022. "Multi-modal molecular programs regulate melanoma cell state," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    3. Nanda Horeweg & Hagma H. Workel & Dominik Loiero & David N. Church & Lisa Vermij & Alicia Léon-Castillo & Ricki T. Krog & Stephanie M. Boer & Remi A. Nout & Melanie E. Powell & Linda R. Mileshkin & He, 2022. "Tertiary lymphoid structures critical for prognosis in endometrial cancer patients," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    4. Yunqiao Li & Raag Bhargava & Jenny Tuyet Tran & Tanya R. Blane & Linghang Peng & Fangkun Luan & Zhe Huang & Zefan Zhang & Yunfan Sun & Changchun Xiao & David Nemazee, 2025. "Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity," Nature Communications, Nature, vol. 16(1), pages 1-16, December.
    5. Akshay J. Patel & Zena N. Willsmore & Naeem Khan & Alex Richter & Babu Naidu & Mark T. Drayson & Sophie Papa & Andrew Cope & Sophia N. Karagiannis & Esperanza Perucha & Gary W. Middleton, 2022. "Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    6. Li Yuan & Guo-Dong Jia & Xiao-Fei Lv & Si-Yi Xie & Shan-Shan Guo & Da-Feng Lin & Li-Ting Liu & Dong-Hua Luo & Yi-Fu Li & Shen-Wen Deng & Ling Guo & Mu-Sheng Zeng & Xiu-Yu Cai & Sai-Lan Liu & Xue-Song , 2023. "Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    7. Jieqiong Liu & Ying Wang & Zhenluan Tian & Ying Lin & Hengyu Li & Zhaowen Zhu & Qiang Liu & Shicheng Su & Yinduo Zeng & Weijuan Jia & Yaping Yang & Shengqiang Xu & Herui Yao & Wen Jiang & Erwei Song, 2022. "Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    8. Matthew T. Campbell & Surena F. Matin & Alda L. Tam & Rahul A. Sheth & Kamran Ahrar & Rebecca S. Tidwell & Priya Rao & Jose A. Karam & Christopher G. Wood & Nizar M. Tannir & Eric Jonasch & Jianjun Ga, 2021. "Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    9. Zhenzhen Xun & Xinyu Ding & Yao Zhang & Benyan Zhang & Shujing Lai & Duowu Zou & Junke Zheng & Guoqiang Chen & Bing Su & Leng Han & Youqiong Ye, 2023. "Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    10. Saba Nayar & Jason D. Turner & Saba Asam & Eanna Fennell & Matthew Pugh & Serena Colafrancesco & Onorina Berardicurti & Charlotte G. Smith & Joe Flint & Ana Teodosio & Valentina Iannizzotto & David H., 2025. "Molecular and spatial analysis of tertiary lymphoid structures in Sjogren’s syndrome," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    11. Hao Li & Meng-Jie Zhang & Boxin Zhang & Wen-Ping Lin & Shu-Jin Li & Dian Xiong & Qing Wang & Wen-Da Wang & Qi-Chao Yang & Cong-Fa Huang & Wei-Wei Deng & Zhi-Jun Sun, 2025. "Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer," Nature Communications, Nature, vol. 16(1), pages 1-20, December.
    12. Yang Liu & Shuang-Yan Ye & Shuai He & Dong-Mei Chi & Xiu-Zhi Wang & Yue-Feng Wen & Dong Ma & Run-Cong Nie & Pu Xiang & You Zhou & Zhao-Hui Ruan & Rou-Jun Peng & Chun-Ling Luo & Pan-Pan Wei & Guo-Wang , 2024. "Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    13. Roberta Piras & Emily Y. Ko & Connor Barrett & Marco Simone & Xianzhi Lin & Marina T. Broz & Fernando H. G. Tessaro & Mireia Castillo-Martin & Carlos Cordon-Cardo & Helen S. Goodridge & Dolores Vizio , 2022. "circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    14. Jianming Xu & Yi Li & Qingxia Fan & Yongqian Shu & Lei Yang & Tongjian Cui & Kangsheng Gu & Min Tao & Xiuwen Wang & Chengxu Cui & Nong Xu & Juxiang Xiao & Quanli Gao & Yunpeng Liu & Tao Zhang & Yuxian, 2022. "Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    15. Marina T. Broz & Emily Y. Ko & Kristin Ishaya & Jinfen Xiao & Marco Simone & Xen Ping Hoi & Roberta Piras & Basia Gala & Fernando H. G. Tessaro & Anja Karlstaedt & Sandra Orsulic & Amanda W. Lund & Ke, 2024. "Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    16. Jia Wei & Xiaofeng Lu & Qin Liu & Yao Fu & Song Liu & Yang Zhao & Jiawei Zhou & Hui Chen & Meng Wang & Lin Li & Ju Yang & Fangcen Liu & Liming Zheng & Haitao Yin & Yang Yang & Chong Zhou & Ping Zeng &, 2023. "Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    17. Sangeeta Goswami & Jianjun Gao & Sreyashi Basu & Daniel D. Shapiro & Jose A. Karam & Rebecca Slack Tidwell & Kamran Ahrar & Matthew T. Campbell & Yu Shen & Alexandro E. Trevino & Aaron T. Mayer & Alex, 2025. "Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial," Nature Communications, Nature, vol. 16(1), pages 1-13, December.
    18. Marina Baretti & Ludmila Danilova & Jennifer N. Durham & Courtney B. Betts & Leslie Cope & Dimitrios N. Sidiropoulos & Joseph A. Tandurella & Soren Charmsaz & Nicole Gross & Alexei Hernandez & Won Jin, 2024. "Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    19. Julia Paczkowska & Ming Tang & Kyle T. Wright & Li Song & Kelsey Luu & Vignesh Shanmugam & Emma L. Welsh & Jason L. Weirather & Naomi Besson & Harrison Olszewski & Billie A. Porter & Kathleen L. Pfaff, 2024. "Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    20. Liang Zhang & Boxin Zhang & Meng-Jie Zhang & Wenlang Li & Hao Li & Yantian Jiao & Qi-Chao Yang & Shuo Wang & Yuan-Tong Liu & An Song & Hai-Tao Feng & Jianwei Sun & Ryan T. K. Kwok & Jacky W. Y. Lam & , 2025. "Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy," Nature Communications, Nature, vol. 16(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58678-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.